Paper41700699
Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability.
Pham NTH and 8 others. Protein Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability. Papers, record 41700699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41700699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Galectins | Major topic |
| Humans | |
| Allosteric Regulation | |
| Models, Molecular | |
| Protein Stability | |
| Apoptosis | |
| Binding Sites | |
| Protein Multimerization |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| RGPIN-2017-06091 | Natural Sciences and Engineering Research Council of Canada (CREATE APRENTICE) | RGPIN201706 | PubMed | NIH RePORTER | |
| RGPIN-2022-04368 | Natural Sciences and Engineering Research Council of Canada (CREATE APRENTICE) | RGPIN202204 | PubMed | NIH RePORTER | |
| RGPIN-2022-04721 | Natural Sciences and Engineering Research Council of Canada (CREATE APRENTICE) | RGPIN202204 | PubMed | NIH RePORTER | |
| 281993 | Fonds de Recherche du Québec - Santé | PubMed | PubMed | ||
| 287239 | Fonds de Recherche du Québec - Santé | PubMed | PubMed | ||
| Canadian Light Source | PubMed | PubMed | |||
| Canadian Glycomics Network | PubMed | PubMed |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23967302 | Expression of galectin-7 is induced in breast cancer cells by mutant p53. | PLoS One | 2013 | https://conductscience.org/library/papers/23967302 | PubMed |
| 2 | 12682633 | Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. | Leukemia | 2003 | https://conductscience.org/library/papers/12682633 | PubMed |
| 3 | 28454344 | Galectin-7 promotes the invasiveness of human oral squamous cell carcinoma cells via activation of ERK and JNK signaling. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28454344 | PubMed |
| 4 | 28474020 | Characterization of the structure, dynamics and allosteric pathways of human NPP1 in its free form and substrate-bound complex from molecular modeling. | Mol Biosyst | 2017 | https://conductscience.org/library/papers/28474020 | PubMed |
| 5 | 34827718 | Functions and Inhibition of Galectin-7, an Emerging Target in Cellular Pathophysiology. | Biomolecules | 2021 | https://conductscience.org/library/papers/34827718 | PubMed |
| 6 | 34673030 | Perturbing dimer interactions and allosteric communication modulates the immunosuppressive activity of human galectin-7. | J Biol Chem | 2021 | https://conductscience.org/library/papers/34673030 | PubMed |
| 7 | 32752662 | Scalable molecular dynamics on CPU and GPU architectures with NAMD. | J Chem Phys | 2020 | https://conductscience.org/library/papers/32752662 | PubMed |
| 8 | 25367122 | Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25367122 | PubMed |
| 9 | 20382700 | Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. | Am J Pathol | 2010 | https://conductscience.org/library/papers/20382700 | PubMed |
| 10 | 26933916 | Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. | Oncotarget | 2016 | https://conductscience.org/library/papers/26933916 | PubMed |
| 11 | 36766779 | Placental Galectins in Cancer: Why We Should Pay More Attention. | Cells | 2023 | https://conductscience.org/library/papers/36766779 | PubMed |
| 12 | 22575017 | Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. | J Med Chem | 2012 | https://conductscience.org/library/papers/22575017 | PubMed |
| 13 | 15549884 | A modified TIP3P water potential for simulation with Ewald summation. | J Chem Phys | 2004 | https://conductscience.org/library/papers/15549884 | PubMed |
| 14 | 23564797 | Clinical significance of galectin-7 in epithelial ovarian cancer. | Anticancer Res | 2013 | https://conductscience.org/library/papers/23564797 | PubMed |
| 15 | 26543238 | Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin. | Oncotarget | 2015 | https://conductscience.org/library/papers/26543238 | PubMed |
| 16 | 28594391 | Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28594391 | PubMed |
| 17 | 21616652 | Glycosylation, galectins and cellular signaling. | Curr Opin Cell Biol | 2011 | https://conductscience.org/library/papers/21616652 | PubMed |
| 18 | 12223273 | Binding and cross-linking properties of galectins. | Biochim Biophys Acta | 2002 | https://conductscience.org/library/papers/12223273 | PubMed |
| 19 | 29343868 | Galectin-13, a different prototype galectin, does not bind β-galacto-sides and forms dimers via intermolecular disulfide bridges between Cys-136 and Cys-138. | Sci Rep | 2018 | https://conductscience.org/library/papers/29343868 | PubMed |
| 20 | 21685687 | Beamline 08ID-1, the prime beamline of the Canadian Macromolecular Crystallography Facility. | J Synchrotron Radiat | 2011 | https://conductscience.org/library/papers/21685687 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41700699 | Network-based allosteric analysis of galectin-7: Key residues dictate functional communication and stability. | Protein Sci | 2026 | https://conductscience.org/library/papers/41700699 |
Source PubMed
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| LGALS13 | 29124 | PubTator's text mining | https://conductscience.org/library/genes/29124 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
| LGALS7 | 3963 | PubTator's text mining | https://conductscience.org/library/genes/3963 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| TCF3 | 6929 | PubTator's text mining | https://conductscience.org/library/genes/6929 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41700699
GET https://conductscience.org/api/papers/v1/41700699/references?page=2